NCT04487457View on ClinicalTrials.gov

Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 3, 2021

Primary Completion Date

September 29, 2022

Study Completion Date

September 29, 2022

Conditions

Non Small Cell Lung CancerBladder CancerENT Cancer

Interventions

OTHER

Blood samples

Trial Locations (2)

37044

Medical oncology department, University Hospital, Tours, Tours

Pneumology department, University Hospital, Tours, Tours

All Listed Sponsors

lead

University Hospital, Tours

OTHER

NCT04487457 - Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy | Biotech Hunter | Biotech Hunter